HPV vax program prevents rare paediatric respiratory disease

Quadrivalent HPV vaccination is reducing cases of a rare but “miserable and expensive” respiratory disease in children, according to a world-first report from Australia.

Surveillance of juvenile-onset recurrent respiratory papillomatosis (JoRPP) cases shows new diagnoses have declined in the five to 10 years since universal HPV vaccination began in 2007.

JoRPP, believed to arise from vertical transmission of HPV type 6 or 11, causes recurrent warty lesions  on the larynx and often requires multiple ablative procedures in childhood